NL-OMON23572已完成不适用
Phase 1 study of irinotecan and cisplatin with concurrent thoracic radiotherapy in patients with limited-disease small cell lung cancer (LD-SCLC).
Department of Medical OncologyErasmus University Medical Center / Daniel den Hoed Kliniek3008 AE ROTTERDAM0 个研究点目标入组 9 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
ung Cancer. 2008 Jul;61(1):123-8. Epub 2008 Jan 7.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Cytologically or histologically proven SCLC;
- •2. Disease confined to one hemithorax without evidence of cytologically proven malignant pleural effusion;
排除标准
- •1. Other serious ilnesses;
- •2. Concurrent therapy with other anti-cancer drugs;
研究者
相似试验
Unknown
1 期
A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Advanced Non-Small Cell Lung CancerNCT00874328National Cancer Center, Korea74
终止
2 期
Docetaxel in Non Small Cell Lung Cancer (NSCLC)Carcinoma, Non-Small-Cell LungNCT00263016Sanofi50
招募中
不适用
A phase II study of Irinotecan and cisplatin combination chemotherapy in metastatic, unresectable esophageal cancerNeoplasmsKCT0000670Seoul National University Hospital23
已完成
1 期
Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerLung CancerNCT00059761Radiation Therapy Oncology Group36
已完成
2 期
Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerLung CancerNCT00469898Vanderbilt-Ingram Cancer Center50